Virbac (Virbac) Additional Paid-In Capital : $7 Mil(As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Virbac Additional Paid-In Capital?

Virbac's quarterly additional paid-in capital increased from Dec. 2022 ($7 Mil) to Jun. 2023 ($7 Mil) and increased from Jun. 2023 ($7 Mil) to Dec. 2023 ($7 Mil).

Virbac's annual additional paid-in capital declined from Dec. 2021 ($7 Mil) to Dec. 2022 ($7 Mil) but then increased from Dec. 2022 ($7 Mil) to Dec. 2023 ($7 Mil).

Virbac Additional Paid-In Capital Historical Data

The historical data trend for Virbac's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virbac Additional Paid-In Capital Chart

Virbac Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

7.38

6.92

7.13

Virbac Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															7.38	6.91	6.92	7.08	7.13

Virbac Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Virbac Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Virbac's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Virbac (Virbac) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (OTCPK:VRBCF) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

0NM7:UK VIRP:France V16:Germany

Address

2065m LID, 1 ere avenue, Carros, FRA, 06516

Website

https://www.virbac.com

Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America.